The World Health Organisation (WHO) has approved an antiviral drug, molnupiravir, for the treatment of omicron variant of the deadly coronavirus. WHO gave the approval in the ninth update on COVID-19 therapeutics made available on its website on Thursday. READ ALSO: COVID-19: Nigerian Gov’t to vaccinate Nigerians in Churches on Sundays This will be the first oral antiviral drug included in the treatment for COVID-19 after the development of vaccines in mid 2020. The body urged stakeholders and health workers to ensure active monitoring for drug safety, along with other strategies to mitigate potential...